{
  "timestamp": "2026-02-01T16:59:15.549474",
  "queries": 12,
  "harness_version": "2.0",
  "baseline": {
    "mode": "baseline",
    "timestamp": "2026-02-01T17:04:30.070742",
    "total_queries": 12,
    "successful": 12,
    "failed": 0,
    "suspect": 0,
    "avg_latency_ms": 25306.75,
    "not_found_rate": 0.25,
    "avg_verified_citations": 4.0,
    "avg_unverified_citations": 0.08333333333333333,
    "scotus_coverage": 0.0,
    "en_banc_coverage": 0.0,
    "phase1_trigger_rate": 0.0,
    "avg_candidates_added": 0.0,
    "avg_phase1_latency_ms": 0.0,
    "avg_answer_length": 4671.166666666667,
    "results": [
      {
        "run_id": "5e4dd560-8c62-4e5d-a09b-3f19174b5e35",
        "query_id": "multi_issue_101_112_a",
        "query": "What are the requirements for patent eligibility under Alice 101 and written description under 112(a)?",
        "conversation_id": "eval_multi_issue_101_112_a_1769965156_233ecf5f",
        "success": true,
        "generated_at": "2026-02-01T16:59:55.704220",
        "final_answer_text": "### Immediate Answer:\nUnder **Alice 101**, patent eligibility requires that the claimed invention:\n1. **Step 1**: Is not directed to a patent-ineligible concept, such as an abstract idea, law of nature, or natural phenomenon. (([1] *Bilski v. Kappos*) *Universal Secure Registry LLC v. Apple Inc.*), (([2] *Alice Corp. v. CLS Bank International*) *Aatrix Software, Inc. v. Green Shades Software, Inc.*)\n2. **Step 2**: If it is directed to such a concept, the claim must include an \"inventive concept\"",
        "answer_length": 8191,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 39009,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "local_eval_multi_issue_101_112_b_1769965196_7fbfd183",
        "query_id": "multi_issue_101_112_b",
        "query": "When is a software claim both abstract under 101 and lacking enablement under 112?",
        "conversation_id": "eval_multi_issue_101_112_b_1769965196_7fbfd183",
        "success": true,
        "generated_at": "2026-02-01T17:00:24.732959",
        "final_answer_text": "NOT FOUND IN PROVIDED OPINIONS.\n\n**New cases were ingested but no relevant excerpts found.**\n\nIngested: Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., Williamson v. Citrix Online, LLC, Vasudevan Software, Inc. v. Tibco Software, Inc.\n\nThe topic may require more specialized case law. Try refining your search terms.",
        "answer_length": 316,
        "not_found": true,
        "verified_citations": 0,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 0,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 28227,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [],
        "_replay_packet_available": false,
        "_suspect": false
      },
      {
        "run_id": "39cf922f-0cde-41de-b54e-fc2aff46f265",
        "query_id": "multi_issue_103_112",
        "query": "How does obviousness analysis differ from written description requirements for genus claims?",
        "conversation_id": "eval_multi_issue_103_112_1769965225_ada0a696",
        "success": true,
        "generated_at": "2026-02-01T17:00:53.016472",
        "final_answer_text": "## Immediate Answer:\nObviousness analysis and written description requirements for genus claims differ in their focus and purpose. Obviousness analysis under 35 U.S.C. \u00a7 103 evaluates whether the claimed invention as a whole would have been obvious to a person of ordinary skill in the art at the time of the invention, considering the prior art. In contrast, the written description requirement under 35 U.S.C. \u00a7 112, \u00b6 1 ensures that the patent specification demonstrates that the inventor was in p",
        "answer_length": 8514,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 27450,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "5c7c7f01-fd4a-47b1-85fc-95f081055467",
        "query_id": "thin_retrieval_rare_doctrine",
        "query": "What is the Therasense materiality standard for inequitable conduct?",
        "conversation_id": "eval_thin_retrieval_rare_doctrine_1769965253_4510b458",
        "success": true,
        "generated_at": "2026-02-01T17:01:17.904791",
        "final_answer_text": "The Therasense materiality standard for inequitable conduct requires \"but-for materiality,\" meaning that undisclosed prior art or information is material if the U.S. Patent and Trademark Office (PTO) would not have allowed a claim had it been aware of the undisclosed information. Specifically, the court in *Therasense, Inc. v. Becton, Dickinson & Co.* stated:\n\n1. \"The materiality required to establish inequitable conduct is but-for materiality.\" (([1] *Belcher Pharmaceuticals, LLC v. Hospira, In",
        "answer_length": 3487,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 24047,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "68603e92-e440-4ef7-9af2-adeb13344986",
        "query_id": "thin_retrieval_rare_terms",
        "query": "How does the doctrine of equivalents apply to prosecution history estoppel after Festo?",
        "conversation_id": "eval_thin_retrieval_rare_terms_1769965278_19e1a4f1",
        "success": true,
        "generated_at": "2026-02-01T17:01:44.587439",
        "final_answer_text": "The doctrine of equivalents allows a patentee to claim infringement for insubstantial alterations to a patented invention that were not literally captured in the patent claims. However, the doctrine is limited by prosecution history estoppel, which prevents a patentee from recapturing subject matter surrendered during the prosecution of the patent. The Supreme Court's decision in *Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co.*, 535 U.S. 722 (2002) (\"Festo VIII\"), clarified the application ",
        "answer_length": 5137,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 4,
          "MODERATE": 1,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 25846,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "040dbe56-ff8c-4e73-b68d-611d8a6a69d1",
        "query_id": "thin_retrieval_specific_case",
        "query": "What is the Williamson v. Citrix test for means-plus-function claim construction?",
        "conversation_id": "eval_thin_retrieval_specific_case_1769965305_b489bd54",
        "success": true,
        "generated_at": "2026-02-01T17:02:05.092732",
        "final_answer_text": "The Williamson v. Citrix test for determining whether a claim term invokes means-plus-function treatment under 35 U.S.C. \u00a7 112, \u00b6 6 (pre-AIA) or \u00a7 112(f) (post-AIA) is as follows:\n\n1. **Essential Inquiry**: The key question is whether the words of the claim are understood by persons of ordinary skill in the art to have a sufficiently definite meaning as the name for structure. If the claim term fails to recite sufficiently definite structure or recites function without sufficient structure for p",
        "answer_length": 3988,
        "not_found": false,
        "verified_citations": 2,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 2,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 2,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 19668,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "de129340-d453-42c0-b6bf-b6bf48431d8b",
        "query_id": "named_case_doctrine_conflict",
        "query": "Does KSR or Graham provide the correct framework for motivation to combine references?",
        "conversation_id": "eval_named_case_doctrine_conflict_1769965325_872d8045",
        "success": true,
        "generated_at": "2026-02-01T17:02:27.759206",
        "final_answer_text": "The correct framework for evaluating the motivation to combine references is provided by **Graham v. John Deere Co.**, as clarified and expanded upon by **KSR International Co. v. Teleflex Inc.**. Both cases are foundational, but KSR refined and emphasized the flexibility of the Graham framework.\n\n## Immediate Answer:\nGraham provides the foundational framework for determining obviousness, including the motivation to combine references, while KSR clarified and expanded this framework by rejecting",
        "answer_length": 6980,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 21837,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "local_eval_named_case_doctrine_conflict_2_1769965348_48b16236",
        "query_id": "named_case_doctrine_conflict_2",
        "query": "When Alice conflicts with Bilski on abstract idea determination, which controls?",
        "conversation_id": "eval_named_case_doctrine_conflict_2_1769965348_48b16236",
        "success": true,
        "generated_at": "2026-02-01T17:02:52.739864",
        "final_answer_text": "NOT FOUND IN PROVIDED OPINIONS.\n\n**Potentially relevant cases found but not yet indexed:**\n- Athena Diagnostics, Inc. v. Mayo Collaborative Servs., LLC\n- Ultramercial, Inc. v. Hulu, Llc\n- CLS Bank International v. Alice Corp. Pty. Ltd.\n\nThe ingested opinions do not contain information relevant to your query. Try ingesting additional opinions or refining your search.",
        "answer_length": 368,
        "not_found": true,
        "verified_citations": 0,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 0,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 24179,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [],
        "_replay_packet_available": false,
        "_suspect": false
      },
      {
        "run_id": "c1fa3c2f-5d68-420b-8a5a-648ae46f9801",
        "query_id": "enablement_heavy_1",
        "query": "What amount of experimentation is undue under the Wands factors for biological claims?",
        "conversation_id": "eval_enablement_heavy_1_1769965373_1b74257b",
        "success": true,
        "generated_at": "2026-02-01T17:03:20.962650",
        "final_answer_text": "The provided excerpts do not explicitly define the amount of experimentation that constitutes \"undue\" under the Wands factors for biological claims. However, the Wands factors themselves are referenced in several excerpts as the framework for determining whether the experimentation required to practice a claimed invention is undue. These factors include considerations such as the quantity of experimentation necessary, the amount of guidance provided in the specification, the presence or absence ",
        "answer_length": 7071,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 27393,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "7d9c3df8-73b2-4f6c-9ed7-544aa58259e2",
        "query_id": "enablement_heavy_2",
        "query": "How do courts apply the full scope of enablement requirement to genus claims covering thousands of species?",
        "conversation_id": "eval_enablement_heavy_2_1769965401_99927934",
        "success": true,
        "generated_at": "2026-02-01T17:03:45.138435",
        "final_answer_text": "Courts apply the full scope of enablement requirement to genus claims by assessing whether the patent's specification enables a person of ordinary skill in the art to make and use the full scope of the claimed genus without undue experimentation. This analysis often involves evaluating the breadth of the claims, the guidance provided in the specification, the predictability of the art, and the amount of experimentation required. Below is a detailed explanation based on the provided excerpts:\n\n--",
        "answer_length": 4926,
        "not_found": false,
        "verified_citations": 6,
        "unverified_citations": 1,
        "tier_counts": {
          "STRONG": 6,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 1
        },
        "total_sources": 7,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 23270,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "abc340b9-eb2b-44de-aa6a-07a5097126b3",
        "query_id": "obviousness_combine_1",
        "query": "After KSR, what evidence rebuts a prima facie case of obviousness for combining prior art references?",
        "conversation_id": "eval_obviousness_combine_1_1769965425_32277f9a",
        "success": true,
        "generated_at": "2026-02-01T17:04:10.716389",
        "final_answer_text": "## Immediate Answer:\nEvidence that rebuts a prima facie case of obviousness for combining prior art references includes objective indicia of nonobviousness, such as unexpected results, commercial success, long-felt but unresolved needs, failure of others, and evidence that the prior art teaches away from the claimed invention. Additionally, evidence showing that the prior art does not enable the claimed invention or that there was no reasonable expectation of success in combining the references ",
        "answer_length": 6851,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 24737,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "8bbc09de-dbdd-472d-ac96-9e6e85090b43",
        "query_id": "obviousness_combine_2",
        "query": "When can an examiner combine three or more prior art references to reject claims as obvious under 103?",
        "conversation_id": "eval_obviousness_combine_2_1769965451_d2a09860",
        "success": true,
        "generated_at": "2026-02-01T17:04:29.569957",
        "final_answer_text": "The provided excerpts do not explicitly address the specific conditions under which an examiner may combine three or more prior art references to reject claims as obvious under 35 U.S.C. \u00a7 103. NOT FOUND IN PROVIDED OPINIONS.",
        "answer_length": 225,
        "not_found": true,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 18018,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      }
    ]
  },
  "phase1": {
    "mode": "phase1",
    "timestamp": "2026-02-01T17:10:01.859058",
    "total_queries": 12,
    "successful": 12,
    "failed": 0,
    "suspect": 0,
    "avg_latency_ms": 26821.083333333332,
    "not_found_rate": 0.25,
    "avg_verified_citations": 3.3333333333333335,
    "avg_unverified_citations": 0.0,
    "scotus_coverage": 0.0,
    "en_banc_coverage": 0.0,
    "phase1_trigger_rate": 0.0,
    "avg_candidates_added": 0.0,
    "avg_phase1_latency_ms": 0.0,
    "avg_answer_length": 4498.0,
    "results": [
      {
        "run_id": "436143b5-889c-4a06-8fda-df2c3bb07341",
        "query_id": "multi_issue_101_112_a",
        "query": "What are the requirements for patent eligibility under Alice 101 and written description under 112(a)?",
        "conversation_id": "eval_multi_issue_101_112_a_1769965470_cf198de3",
        "success": true,
        "generated_at": "2026-02-01T17:05:25.509503",
        "final_answer_text": "Under the provided excerpts, the requirements for patent eligibility under **35 U.S.C. \u00a7 101** (as interpreted by the Alice/Mayo framework) and the written description requirement under **35 U.S.C. \u00a7 112(a)** are as follows:\n\n---\n\n### **Patent Eligibility under Alice (\u00a7 101)**\n\nThe Alice/Mayo framework establishes a two-step test for determining patent eligibility under \u00a7 101:\n\n1. **Step One**: Determine whether the claims are directed to a patent-ineligible concept, such as a law of nature, nat",
        "answer_length": 6384,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 55100,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "local_eval_multi_issue_101_112_b_1769965526_78ddd5fb",
        "query_id": "multi_issue_101_112_b",
        "query": "When is a software claim both abstract under 101 and lacking enablement under 112?",
        "conversation_id": "eval_multi_issue_101_112_b_1769965526_78ddd5fb",
        "success": true,
        "generated_at": "2026-02-01T17:06:01.543444",
        "final_answer_text": "NOT FOUND IN PROVIDED OPINIONS.\n\n**New cases were ingested but no relevant excerpts found.**\n\nIngested: Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., Williamson v. Citrix Online, LLC, Vasudevan Software, Inc. v. Tibco Software, Inc.\n\nThe topic may require more specialized case law. Try refining your search terms.",
        "answer_length": 316,
        "not_found": true,
        "verified_citations": 0,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 0,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 35232,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [],
        "_replay_packet_available": false,
        "_suspect": false
      },
      {
        "run_id": "121e4260-7380-47dc-bc8f-d0adf8d0db1f",
        "query_id": "multi_issue_103_112",
        "query": "How does obviousness analysis differ from written description requirements for genus claims?",
        "conversation_id": "eval_multi_issue_103_112_1769965562_e861df50",
        "success": true,
        "generated_at": "2026-02-01T17:06:38.088595",
        "final_answer_text": "## Immediate Answer:\nObviousness analysis under 35 U.S.C. \u00a7 103 focuses on whether the claimed invention would have been obvious to a person of ordinary skill in the art at the time of invention, considering the prior art. In contrast, the written description requirement under 35 U.S.C. \u00a7 112, \u00b6 1, ensures that the patent specification demonstrates that the inventor was in possession of the claimed invention as of the filing date, including sufficient disclosure to support the claimed genus.\n\n##",
        "answer_length": 8103,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 35696,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "82255dab-f10e-4696-ba5b-7e36710cc4a6",
        "query_id": "thin_retrieval_rare_doctrine",
        "query": "What is the Therasense materiality standard for inequitable conduct?",
        "conversation_id": "eval_thin_retrieval_rare_doctrine_1769965598_4d95677c",
        "success": true,
        "generated_at": "2026-02-01T17:06:58.352751",
        "final_answer_text": "The Therasense materiality standard for inequitable conduct requires \"but-for materiality,\" meaning that undisclosed prior art or information is material if \"the PTO would not have allowed a claim had it been aware of the undisclosed reference.\" This standard is applied using the preponderance of the evidence standard and giving claims their broadest reasonable construction during examination. Additionally, the court clarified that \"even if a district court does not invalidate a claim based on a",
        "answer_length": 2528,
        "not_found": false,
        "verified_citations": 3,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 3,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 3,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 19434,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "63859566-c71e-4d10-91d0-bd182514a744",
        "query_id": "thin_retrieval_rare_terms",
        "query": "How does the doctrine of equivalents apply to prosecution history estoppel after Festo?",
        "conversation_id": "eval_thin_retrieval_rare_terms_1769965618_c48fa534",
        "success": true,
        "generated_at": "2026-02-01T17:07:22.300844",
        "final_answer_text": "The doctrine of equivalents allows a patentee to claim infringement for insubstantial alterations to a patented invention that were not literally captured in the patent claims. However, the application of the doctrine is limited by prosecution history estoppel, which prevents a patentee from recapturing subject matter surrendered during prosecution to obtain a patent. The Supreme Court's decision in *Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co.*, 535 U.S. 722 (2002) (\"Festo VIII\"), clarif",
        "answer_length": 8696,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 23116,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "caffbce9-35e0-487f-9cab-bf703d0bc258",
        "query_id": "thin_retrieval_specific_case",
        "query": "What is the Williamson v. Citrix test for means-plus-function claim construction?",
        "conversation_id": "eval_thin_retrieval_specific_case_1769965642_6fea75fb",
        "success": true,
        "generated_at": "2026-02-01T17:07:38.412820",
        "final_answer_text": "The Williamson v. Citrix test for determining whether a claim term invokes means-plus-function treatment under 35 U.S.C. \u00a7 112, \u00b6 6 (pre-AIA) or \u00a7 112(f) (post-AIA) is as follows:\n\n1. **Essential Inquiry**: The key question is whether the words of the claim are understood by persons of ordinary skill in the art to have a sufficiently definite meaning as the name for structure. If the claim term does not recite sufficient structure, it is treated as a means-plus-function limitation. (([1] *WILLIA",
        "answer_length": 4848,
        "not_found": false,
        "verified_citations": 2,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 2,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 2,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 15282,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "local_eval_named_case_doctrine_conflict_1769965658_9f7ddee1",
        "query_id": "named_case_doctrine_conflict",
        "query": "Does KSR or Graham provide the correct framework for motivation to combine references?",
        "conversation_id": "eval_named_case_doctrine_conflict_1769965658_9f7ddee1",
        "success": true,
        "generated_at": "2026-02-01T17:07:51.747697",
        "final_answer_text": "AMBIGUOUS QUERY \u2014 MULTIPLE MATCHES FOUND  \nThe provided excerpts include multiple Federal Circuit decisions discussing the frameworks established by *KSR International Co. v. Teleflex Inc.* and *Graham v. John Deere Co.* for determining motivation to combine references. Please specify which case or issue you want addressed:  \n- *KSR International Co. v. Teleflex Inc.* (Opinion ID: 4c82cca6-d846-40f9-9a5f-35042df9ab96)  \n- *Graham v. John Deere Co.* (Opinion ID: a4c215a7-a6f3-4d0d-869c-e33ab635c2",
        "answer_length": 802,
        "not_found": false,
        "verified_citations": 0,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 0,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 12533,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [],
        "_replay_packet_available": false,
        "_suspect": false
      },
      {
        "run_id": "local_eval_named_case_doctrine_conflict_2_1769965672_2756c5d3",
        "query_id": "named_case_doctrine_conflict_2",
        "query": "When Alice conflicts with Bilski on abstract idea determination, which controls?",
        "conversation_id": "eval_named_case_doctrine_conflict_2_1769965672_2756c5d3",
        "success": true,
        "generated_at": "2026-02-01T17:08:18.954660",
        "final_answer_text": "NOT FOUND IN PROVIDED OPINIONS.\n\n**New cases were ingested but no relevant excerpts found.**\n\nIngested: Athena Diagnostics, Inc. v. Mayo Collaborative Servs., LLC, Ultramercial, Inc. v. Hulu, Llc, CLS Bank International v. Alice Corp. Pty. Ltd.\n\nThe topic may require more specialized case law. Try refining your search terms.",
        "answer_length": 326,
        "not_found": true,
        "verified_citations": 0,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 0,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 0,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 26405,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [],
        "_replay_packet_available": false,
        "_suspect": false
      },
      {
        "run_id": "cc579b20-c84e-4567-a526-86c8fb0a9912",
        "query_id": "enablement_heavy_1",
        "query": "What amount of experimentation is undue under the Wands factors for biological claims?",
        "conversation_id": "eval_enablement_heavy_1_1769965699_6f9fd215",
        "success": true,
        "generated_at": "2026-02-01T17:08:41.635535",
        "final_answer_text": "The provided excerpts do not explicitly define what amount of experimentation is considered \"undue\" under the Wands factors for biological claims. However, the Wands factors are referenced in multiple cases to determine whether the experimentation required to practice a claimed invention is undue. The factors include considerations such as the quantity of experimentation necessary, the amount of guidance provided in the specification, the presence or absence of working examples, the nature of th",
        "answer_length": 7189,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 21848,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "c7aa9be0-7e22-4e77-8170-51b29331e465",
        "query_id": "enablement_heavy_2",
        "query": "How do courts apply the full scope of enablement requirement to genus claims covering thousands of species?",
        "conversation_id": "eval_enablement_heavy_2_1769965722_6a28e660",
        "success": true,
        "generated_at": "2026-02-01T17:09:16.678063",
        "final_answer_text": "Courts apply the full scope of enablement requirement to genus claims by assessing whether the patent's specification enables a person skilled in the art to make and use the full scope of the claimed genus without undue experimentation. This analysis often involves evaluating the breadth of the claims, the guidance provided in the specification, the predictability of the field, and the amount of experimentation required to practice the full scope of the claims. Below is a detailed explanation ba",
        "answer_length": 7647,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 34193,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "8bf192fb-d8d0-4a7a-bb7e-8d584d01b322",
        "query_id": "obviousness_combine_1",
        "query": "After KSR, what evidence rebuts a prima facie case of obviousness for combining prior art references?",
        "conversation_id": "eval_obviousness_combine_1_1769965757_50229fd8",
        "success": true,
        "generated_at": "2026-02-01T17:09:43.184760",
        "final_answer_text": "Evidence that rebuts a prima facie case of obviousness for combining prior art references includes objective indicia of nonobviousness, such as unexpected results, commercial success, long-felt but unresolved needs, failure of others, and evidence that the prior art teaches away from the claimed invention. The Federal Circuit has consistently emphasized that all evidence must be considered collectively, not just when the decision-maker remains in doubt after reviewing the prior art.\n\n## Detailed",
        "answer_length": 6912,
        "not_found": false,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 25676,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      },
      {
        "run_id": "b49449b2-4e06-41ca-ad67-7fe7695c53d2",
        "query_id": "obviousness_combine_2",
        "query": "When can an examiner combine three or more prior art references to reject claims as obvious under 103?",
        "conversation_id": "eval_obviousness_combine_2_1769965783_89ce3dfd",
        "success": true,
        "generated_at": "2026-02-01T17:10:01.358281",
        "final_answer_text": "The provided excerpts do not explicitly address the specific conditions under which an examiner may combine three or more prior art references to reject claims as obvious under 35 U.S.C. \u00a7 103. NOT FOUND IN PROVIDED OPINIONS.",
        "answer_length": 225,
        "not_found": true,
        "verified_citations": 5,
        "unverified_citations": 0,
        "tier_counts": {
          "STRONG": 0,
          "MODERATE": 5,
          "WEAK": 0,
          "UNVERIFIED": 0
        },
        "total_sources": 5,
        "scotus_present": false,
        "en_banc_present": false,
        "latency_ms": 17338,
        "augmentation_used": {
          "decompose": false,
          "embeddings": false
        },
        "triggers": [],
        "candidates_added": 0,
        "phase1_triggered": false,
        "phase1_latency_ms": 0,
        "retrieval_manifest_snapshot": [
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          "",
          ""
        ],
        "_replay_packet_available": true,
        "_suspect": false
      }
    ]
  },
  "comparison": {
    "baseline": {
      "total_queries": 12,
      "successful": 12,
      "avg_latency_ms": 25306.75,
      "not_found_rate": 0.25,
      "avg_verified_citations": 4.0,
      "scotus_coverage": 0.0
    },
    "phase1": {
      "total_queries": 12,
      "successful": 12,
      "avg_latency_ms": 26821.083333333332,
      "not_found_rate": 0.25,
      "avg_verified_citations": 3.3333333333333335,
      "scotus_coverage": 0.0,
      "phase1_trigger_rate": 0.0,
      "avg_candidates_added": 0.0
    },
    "deltas": {
      "latency_delta_ms": 1514.3333333333321,
      "not_found_delta": 0.0,
      "verified_citations_delta": -0.6666666666666665,
      "scotus_coverage_delta": 0.0
    },
    "improvements": {
      "reduced_not_found": false,
      "more_verified_citations": false,
      "better_scotus_coverage": true
    }
  }
}